Zynex Welcomes a New Leader to its Board
Zynex, Inc. (NASDAQ: ZYXI), a pioneer in innovative medical technology, specializes in the manufacture and sale of non-invasive devices aimed at pain management and rehabilitation. The company has recently appointed Bret Wise to its Board of Directors. Alongside his board role, Wise will also chair the company's Audit Committee.
Dynamic Leadership for Financial Oversight
Steven Dyson, the CEO of Zynex, expressed enthusiasm over Wise’s appointment, stating that he is a great addition to the board. Dyson emphasized the company’s renewed focus on patient and customer success, complemented by a commitment to integrity and compliance. With Mr. Wise’s extensive experience, the company aims to enhance its operational and financial management.
Bret Wise’s Extensive Experience in Medical Devices
Bret Wise brings an impressive background to Zynex, with significant operational and financial management experience in the medical device sector. From 2007 to 2016, he served as Chair and CEO of Dentsply International, followed by a tenure as Executive Chair of Dentsply Sirona until 2017. His career has seen him in various distinguished roles, including President, COO, and CFO within the same organization.
Strategic Contributions to the Medical Device Landscape
Prior to joining Dentsply, Mr. Wise was also CFO for two publicly traded companies and an audit partner with KPMG. His diverse experiences extend to two other public boards, IMS Health Inc. and Pall Corporation. Additionally, he currently contributes to Zest Dental Solutions and the Clinical Advisory Board of the Kansas City University College of Dental Medicine.
A Pivotal Role at Zynex
In his new role, Wise stated, "I am honored to take on this role as Chair of the Audit Committee at such a pivotal time for Zynex." He looks forward to collaborating with fellow board members and the management team to pave the way forward for the company.
Commitment to Financial Integrity
Thomas Sandgaard, the founder and Chair of the Board, expressed pride in welcoming Wise. He noted that Bret's financial expertise will be invaluable as the company maintains its commitment to high standards of financial oversight and transparency. This appointment aligns with Zynex's mission to provide exceptional medical technologies while ensuring responsible financial practices.
Future Prospects
In the context of ongoing challenges in the medical device field, Zynex aims to leverage Wise's expertise to navigate market uncertainties and regulatory requirements effectively. Armed with smart strategies and innovative approaches, the company is ready to embrace future opportunities.
About Zynex, Inc.
Founded in 1996, Zynex develops, manufactures, markets, and sells medical devices for pain management and rehabilitation. Their innovative offerings also include non-invasive monitoring systems for fluid management, sepsis, and laser-based pulse oximetry used in clinical settings.
Investor Relations Contact
Vikram Bajaj, CFO
Frequently Asked Questions
What is Zynex's primary focus as a company?
Zynex focuses on manufacturing non-invasive medical devices for pain management and rehabilitation.
Who is Bret Wise?
Bret Wise is the newly appointed Chair of the Audit Committee at Zynex and has extensive experience in the medical device industry.
What roles did Bret Wise have before joining Zynex?
Prior to his role at Zynex, Wise held significant leadership positions at Dentsply International and KPMG.
Why is Wise's appointment important for Zynex?
His financial expertise is expected to enhance Zynex's commitment to financial oversight and transparency.
When was Zynex founded?
Zynex was founded in 1996 and has grown to be a leader in medical device innovation.
